Dumontet C - Search Results

1

Expression of class III beta tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy.

Dumontet C, Isaac S, Souquet PJ, Bejui-Thivolet F, Pacheco Y, Peloux N, Frankfurter A, Luduena R, Perol M. Dumontet C, et al. Bull Cancer. 2005 Feb;92(2):E25-30. Bull Cancer. 2005. PMID: 15749640 Free article.

2

cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer.

Sève P, Mackey JR, Isaac S, Trédan O, Souquet PJ, Pérol M, Cass C, Dumontet C. Sève P, et al. Among authors: dumontet c. Lung Cancer. 2005 Sep;49(3):363-70. doi: 10.1016/j.lungcan.2005.04.008. Lung Cancer. 2005. PMID: 15923058

3

Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy.

Sève P, Isaac S, Trédan O, Souquet PJ, Pachéco Y, Pérol M, Lafanéchère L, Penet A, Peiller EL, Dumontet C. Sève P, et al. Among authors: dumontet c. Clin Cancer Res. 2005 Aug 1;11(15):5481-6. doi: 10.1158/1078-0432.CCR-05-0285. Clin Cancer Res. 2005. PMID: 16061864

4

Class III beta-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel.

Sève P, Mackey J, Isaac S, Trédan O, Souquet PJ, Pérol M, Lai R, Voloch A, Dumontet C. Sève P, et al. Among authors: dumontet c. Mol Cancer Ther. 2005 Dec;4(12):2001-7. doi: 10.1158/1535-7163.MCT-05-0244. Mol Cancer Ther. 2005. PMID: 16373715

5

Protein abundance of class III beta-tubulin but not Delta2-alpha-tubulin or tau is related to paclitaxel response in carcinomas of unknown primary site.

Sève P, Reiman T, Isaac S, Trillet-Lenoir V, Lafanéchère L, Sawyer M, Dumontet C. Sève P, et al. Among authors: dumontet c. Anticancer Res. 2008 Mar-Apr;28(2B):1161-7. Anticancer Res. 2008. PMID: 18505052 Free article.

6

Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis.

Mialhe A, Lafanechère L, Treilleux I, Peloux N, Dumontet C, Brémond A, Panh MH, Payan R, Wehland J, Margolis RL, Job D. Mialhe A, et al. Among authors: dumontet c. Cancer Res. 2001 Jul 1;61(13):5024-7. Cancer Res. 2001. PMID: 11431336

7

A label-free mass spectrometry method for relative quantitation of β-tubulin isotype expression in human tumor tissue.

Miller LM, Huang Yang CP, Xiao H, Isaac S, Sève P, Dumontet C, Band Horwitz S, Hogue Angeletti R. Miller LM, et al. Among authors: dumontet c. Proteomics Clin Appl. 2012 Oct;6(9-10):502-6. doi: 10.1002/prca.201200018. Proteomics Clin Appl. 2012. PMID: 22996942 Free PMC article.

8

Ixabepilone: targeting betaIII-tubulin expression in taxane-resistant malignancies.

Dumontet C, Jordan MA, Lee FF. Dumontet C, et al. Mol Cancer Ther. 2009 Jan;8(1):17-25. doi: 10.1158/1535-7163.MCT-08-0986. Mol Cancer Ther. 2009. PMID: 19139109 Review.

9

The role of betaIII tubulin in predicting chemoresistance in non-small cell lung cancer.

Sève P, Reiman T, Dumontet C. Sève P, et al. Among authors: dumontet c. Lung Cancer. 2010 Feb;67(2):136-43. doi: 10.1016/j.lungcan.2009.09.007. Epub 2009 Oct 13. Lung Cancer. 2010. PMID: 19828208 Review.

10

[Class III beta tubulin expression in nonsmall cell lung cancer].

Sève P, Dumontet C. Sève P, et al. Among authors: dumontet c. Rev Mal Respir. 2010 Apr;27(4):383-6. doi: 10.1016/j.rmr.2010.03.006. Epub 2010 Mar 25. Rev Mal Respir. 2010. PMID: 20403547 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters